BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2115516)

  • 1. NADPH-cytochrome P-450 reductase. Physical properties and redox behavior in the absence of the FAD moiety.
    Kurzban GP; Howarth J; Palmer G; Strobel HW
    J Biol Chem; 1990 Jul; 265(21):12272-9. PubMed ID: 2115516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 31P-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin/ferredoxin-NADP+ reductase complex.
    Bonants PJ; Müller F; Vervoort J; Edmondson DE
    Eur J Biochem; 1990 Jul; 190(3):531-7. PubMed ID: 2115440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of FAD-dependent cytochrome P450 reductase activity by photoreduction.
    Hodgson AV; Strobel HW
    Anal Biochem; 1996 Dec; 243(1):154-7. PubMed ID: 8954538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase.
    Vermilion JL; Ballou DP; Massey V; Coon MJ
    J Biol Chem; 1981 Jan; 256(1):266-77. PubMed ID: 6778861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of FAD-dependent NADPH-cytochrome P-450 reductase.
    Kurzban GP; Strobel HW
    J Biol Chem; 1986 Jun; 261(17):7824-30. PubMed ID: 3086319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH.
    Oprian DD; Coon MJ
    J Biol Chem; 1982 Aug; 257(15):8935-44. PubMed ID: 6807985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
    Yamamoto K; Kimura S; Shiro Y; Iyanagi T
    Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on FAD- and FMN-binding domains in NADPH-cytochrome P-450 reductase from rabbit liver microsomes.
    Nisimoto Y; Shibata Y
    J Biol Chem; 1982 Nov; 257(21):12532-9. PubMed ID: 6813323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
    Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
    Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between changes in properties and contents of riboflavin derivatives of NADPH-cytochrome P-450 reductase in the liver microsomes of riboflavin-deficient rats.
    Hara T; Taniguchi M
    J Biochem; 1985 Feb; 97(2):473-82. PubMed ID: 3924902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the oxidation of hydroxyl radical scavenging agents after alkaline phosphatase treatment of rat liver microsomes.
    Puntarulo S; Cederbaum AI
    Biochim Biophys Acta; 1991 May; 1074(1):12-8. PubMed ID: 1904277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blue light mediated photoreduction of the flavoprotein NADPH-cytochrome P450 reductase. A Förster-type energy transfer.
    Müller-Enoch D
    Z Naturforsch C J Biosci; 1997; 52(9-10):605-14. PubMed ID: 9373993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the microsomal mixed-function oxidase system: mechanism of action of hepatic NADPH-cytochrome P-450 reductase.
    Iyanagi T; Makino R; Anan FK
    Biochemistry; 1981 Mar; 20(7):1722-30. PubMed ID: 6784758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavins of NADPH-cytochrome P-450 reductase: evidence for structural alteration of flavins in their one-electron-reduced semiquinone states from resonance Raman spectroscopy.
    Sugiyama T; Nisimoto Y; Mason HS; Loehr TM
    Biochemistry; 1985 Jun; 24(12):3012-9. PubMed ID: 3925989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-lived neutral FMN and FAD semiquinones are transient intermediates in cryo-reduced yeast NADPH-cytochrome P450 reductase.
    Davydov RM; Jennings G; Hoffman BM; Podust LM
    Arch Biochem Biophys; 2019 Sep; 673():108080. PubMed ID: 31445894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding.
    Gutierrez A; Paine M; Wolf CR; Scrutton NS; Roberts GC
    Biochemistry; 2002 Apr; 41(14):4626-37. PubMed ID: 11926825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the FAD binding domain of cytochrome P450 reductase.
    Hodgson AV; Strobel HW
    Arch Biochem Biophys; 1996 Jan; 325(1):99-106. PubMed ID: 8554349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis.
    Shen AL; Porter TD; Wilson TE; Kasper CB
    J Biol Chem; 1989 May; 264(13):7584-9. PubMed ID: 2708380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.